China Drugmaker Stocks Drop on Report of Potential Trump Curbs
Chinese drug-related stocks stumbled after a report that the Trump administration has been discussing major restrictions on medicines from the…
Chinese drug-related stocks stumbled after a report that the Trump administration has been discussing major restrictions on medicines from the…
CapVest Partners agreed to buy a majority stake in Stada Arzneimittel AG, ending the long-running saga over the future of…
Guangzhou Innogen Pharmaceutical Group Co., a Chinese biotech firm looking to tap the vast domestic market for obesity drugs, surged…
US regulators delayed their decision on whether to approve the first pill taken on demand for a rare, inherited swelling…